Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa
about
Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of interventionEfficacy of brinzolamide ophthalmic suspension 1% for treatment of a vitelliform macular lesion in a patient with desferrioxamine retinopathy.Recent advances in computer-aided drug design.Ranibizumab for the treatment of degenerative ocular conditions.The relationship of central foveal thickness to urinary iodine concentration in retinitis pigmentosa with or without cystoid macular edema.Virtual screening using molecular simulations.Rapid resolution of retinoschisis with acetazolamideIntravitreal aflibercept (Eylea) injection for cystoid macular edema secondary to retinitis pigmentosa - a first case report and short review of the literatureLong-term characterization of retinal degeneration in rd1 and rd10 mice using spectral domain optical coherence tomographyA case of paclitaxel-induced maculopathy treated with methazolamide.Novel grading system for quantification of cystic macular lesions in Usher syndrome.Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis.Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome.Visual acuity is related to parafoveal retinal thickness in patients with retinitis pigmentosa and macular cysts.Pathogenesis of retinitis pigmentosa associated with apoptosis-inducing mutations in carbonic anhydrase IV.Cloud infrastructures for in silico drug discovery: economic and practical aspects.Unilateral retinitis pigmentosa: 30 years follow-up.Novel mutations in CRB1 gene identified in a chinese pedigree with retinitis pigmentosa by targeted capture and next generation sequencing.Clinical and Rehabilitative Management of Retinitis Pigmentosa: Up-to-Date.Management of Cystoid Macular Edema in Retinitis Pigmentosa.Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia.Effects of beta-adrenergic receptor antagonists on oxidative stress in purified rat retinal ganglion cells.The effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case reportTopical dorzolamide treatment of macular cysts in the enhanced S-cone syndrome patient.Optical Coherence Tomography of Retinal Degeneration in Royal College of Surgeons Rats and Its Correlation with Morphology and ElectroretinographyIntravitreal and subtenon depot triamcinolone as treatment of retinitis pigmentosa associated cystoid macular edema.Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide.Efficacy of carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa: A meta-analysis.Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa.Therapeutic effect of prolonged treatment with topical dorzolamide for cystoid macular oedema in patients with retinitis pigmentosa.The prevalence of macular cysts in patients with clinical cone-rod dystrophy determined by spectral-domain optical coherence tomography.Testing the limits of sensitivity in a solid-state structural investigation by combined X-ray powder diffraction, solid-state NMR, and molecular modelling.Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa.The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa.Macular cystoid spaces in patients with retinal dystrophy.The effect of intravitreal bevacizumab in a rare case of retinal dystrophy with secondary cystoid macular edema.Characterization of a Case of Pigmentary Retinopathy in Sanfilippo Syndrome Type IIIA Associated with Compound Heterozygous Mutations in the SGSH Gene.Reversal of cystoid macular edema in gyrate atrophy patients.Mevalonate kinase deficiency associated with ataxia and retinitis pigmentosa in two brothers with MVK gene mutations.
P2860
Q28076321-676A0E4B-0B42-4F8B-85F8-D64B642D51A0Q31043102-1B1C8A9E-690F-4561-8AEF-7A5175D80438Q33443633-6FA127C3-FD0D-4B8E-B2C5-9D3210649678Q33831237-0C988708-8E1F-480E-85B3-4AA5722B77AFQ34315426-DAC23F11-083F-446D-BECA-5027103DF01DQ34975702-D248FB6F-D0FD-4D8F-9B1A-019C3DF595D0Q35583169-E3678E82-5DF3-4F99-8599-E5743DACCBFEQ35618296-510AC584-71F2-4D6D-91FC-5F156795FA33Q36089356-CD956AE0-9932-4E93-8C14-1A65D4DF642DQ36297617-977D8AB1-C36D-4C42-9F0D-6B66CF31C433Q36364360-351CDFBD-F59C-459B-9AB6-784EEF2C08AEQ36548120-6B6892DE-7AA7-4992-9554-40F291E5E3C1Q36948651-78C472F1-0C5D-41E2-91EC-F892CA7570B8Q36967025-DC069D8A-781F-469E-90F4-7384CD3AF195Q36967902-433F1A71-EBF1-468D-ACC1-4760493907B1Q37117614-2C6A4100-A45E-496E-BB11-94DC693AB0C1Q37196859-7D982A92-E219-4B7B-8088-317F67D22D94Q37588508-FB064798-82BA-4423-8B0B-22140439C972Q37694848-AFF2455C-811D-4901-BBF1-A063FCFAC85BQ37963356-2E6A90FB-9119-4B51-B2F3-7F34ACDAB4E9Q38982477-171A7A5D-8CC1-41FA-9F56-2E5D3F133493Q39791335-70E2FB5E-8A06-4E1F-8BCF-A1FB4CA3B2F0Q40196907-42C388DB-359C-45D4-B663-4378241AE4D6Q41002662-871B71EA-70EF-4920-9B29-E408CD7A6EC6Q41072032-64ADB3FC-58A7-4E7B-83E3-1CC7AC5629E6Q41123013-D1DDE10A-730D-4AD9-924F-BC2E71A66251Q41859736-5B7530CF-9E50-4942-8614-A6B139C6E64EQ41953086-9EDFE3C6-4157-464D-9B63-4D58C57214BAQ42375768-00752121-6D67-4944-BFFE-2970E426CA14Q42409550-711061D2-0424-4D0F-99C0-D5E361CC0651Q44536567-7CCD56F9-4729-427C-BBAD-ECC69C1E3EFFQ44681424-9FBE02D1-1882-4FE8-AECA-CB37D2532ED1Q45376567-E07B64CA-FC70-444A-BA36-BF7CF50C1193Q45384947-C190A128-E69C-42EE-B77A-775D4E2AA914Q46247271-8AC52C00-6EEE-4EA0-889E-BE3AA82A4F99Q46499232-315527D6-5F0F-4B09-90E5-809C77D263ADQ47124376-3470F6C5-6484-40EE-BC92-BE66C0170B56Q47657126-22E79548-81EC-481D-82E7-199D8AB43D98Q50743132-D21643E6-166A-4353-8DDA-7FAD2E263D97Q51186835-515153F8-63AD-480D-BDAB-D7F5A91FA5EF
P2860
Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Topical dorzolamide for the tr ...... ents with retinitis pigmentosa
@ast
Topical dorzolamide for the tr ...... ents with retinitis pigmentosa
@en
Topical dorzolamide for the tr ...... ents with retinitis pigmentosa
@nl
type
label
Topical dorzolamide for the tr ...... ents with retinitis pigmentosa
@ast
Topical dorzolamide for the tr ...... ents with retinitis pigmentosa
@en
Topical dorzolamide for the tr ...... ents with retinitis pigmentosa
@nl
prefLabel
Topical dorzolamide for the tr ...... ents with retinitis pigmentosa
@ast
Topical dorzolamide for the tr ...... ents with retinitis pigmentosa
@en
Topical dorzolamide for the tr ...... ents with retinitis pigmentosa
@nl
P3181
P1476
Topical dorzolamide for the tr ...... ents with retinitis pigmentosa
@en
P2093
Gerald A Fishman
Marsha A Apushkin
P304
P3181
P356
10.1016/J.AJO.2005.12.030
P407
P577
2006-03-20T00:00:00Z